MHDC Pharmaceutical Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
Series C1
- Latest Deal Amount
-
$28.9M
- Investors
-
6
MHDC Pharmaceutical General Information
Description
Developer of biopharmaceutical formulation intended for biopharmaceutical enterprises. The company develops novel biopharmaceutical formulations and conducts industrial-scale production, thereby enabling users to obtain reliable formulation pathways and compliant manufacturing structures.
Contact Information
Website
www.mhdcpharma.comCorporate Office
- 4th Floor, Building 1, Qihanglou
- Number 586 Xihuan Road, Qixian Street, Keqiao District
- Shaoxing, Zhejiang 312000
- China
Corporate Office
- 4th Floor, Building 1, Qihanglou
- Number 586 Xihuan Road, Qixian Street, Keqiao District
- Shaoxing, Zhejiang 312000
- China
MHDC Pharmaceutical Timeline
MHDC Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C1) | 01-Mar-2026 | $28.9M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series C) | 01-Nov-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 05-Jul-2021 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 06-Sep-2018 | $2.92M | $3.68M | Completed | Generating Revenue | |
| 1. Early Stage VC | 22-Feb-2016 | $762K | $762K | Completed | Generating Revenue |
MHDC Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MHDC Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MHDC Pharmaceutical Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shaoxing Shangyu Guokong Shunyun Private Equity Fund Management | Growth/Expansion | Minority | ||
| Zhejiang Collaboration Investment Management | Growth/Expansion | Minority | ||
| Liyuan Venture Capital | Venture Capital | Minority | ||
| Shulan Junjie Capital | Venture Capital | Minority | ||
| Zhejiang Silicon Paradise Asset Management Group | PE/Buyout | Minority |
MHDC Pharmaceutical FAQs
-
When was MHDC Pharmaceutical founded?
MHDC Pharmaceutical was founded in 2011.
-
Where is MHDC Pharmaceutical headquartered?
MHDC Pharmaceutical is headquartered in Shaoxing, China.
-
What is the size of MHDC Pharmaceutical?
MHDC Pharmaceutical has 60 total employees.
-
What industry is MHDC Pharmaceutical in?
MHDC Pharmaceutical’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is MHDC Pharmaceutical a private or public company?
MHDC Pharmaceutical is a Private company.
-
What is MHDC Pharmaceutical’s current revenue?
The current revenue for MHDC Pharmaceutical is .
-
How much funding has MHDC Pharmaceutical raised over time?
MHDC Pharmaceutical has raised $54.8M.
-
Who are MHDC Pharmaceutical’s investors?
Shaoxing Shangyu Guokong Shunyun Private Equity Fund Management, Zhejiang Collaboration Investment Management, Liyuan Venture Capital, Shulan Junjie Capital, and Zhejiang Silicon Paradise Asset Management Group are 5 of 6 investors who have invested in MHDC Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
